Clinical Trial

Study on the Drug Interaction Between Buagafuran and Voriconazole

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated March 9, 2026 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is a non-randomized, open label trial aimed at evaluating the drug interaction between Buagafuran capsules and voriconazole tablets in Chinese adult healthy participants.The research period is 7 days in total.
Trial Details
NCT Number NCT07457203
Lead Sponsor Beijing Union Pharmaceutical Factory Ltd
Conditions Drug Drug Interaction (DDI)
Enrollment 18 participants
Start Date 2026-04
Primary Completion 2026-05 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2026-03-09